PepGen Inc. (PEPG) Halts DMD Program After Trial Miss; Shifts Focus to DM1
Boston-based biotech PepGen Inc.
Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$1.24 | 8,375 | $10,393.38 | 27,805 | 2025-05-30 | Filing | |
$1.36 | 10,000 | $13,550.00 | 113,913 | 2025-04-17 | Filing | |
$1.15 | 41,500 | $47,725.00 | 103,913 | 2025-04-08 | Filing | |
$12.00 | 879,970 | $10,559,640.00 | 4,755,388 | 2022-05-10 | Filing | |
$10.64 | 2,557,593 | $27,212,789.52 | 9,179,273 | 2024-02-09 | Filing |
Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$1.68 | 1,432 | $2,405.76 | 1,568 | 2025-02-26 | Filing | |
$1.68 | 1,527 | $2,565.36 | 1,673 | 2025-02-26 | Filing | |
$18.06 | 7,571 | $136,741.35 | 0 | 2024-07-25 | Filing | |
$18.01 | 201 | $3,619.03 | 0 | 2024-07-24 | Filing | |
$18.20 | 12,625 | $229,804.04 | 0 | 2024-07-18 | Filing |